Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
SPN
The Construction and Maintenance of A Real World Study Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
1 other identifier
observational
2,000
1 country
1
Brief Summary
To establish and maintain a reliable multicenter real-world database for pancreatic SPN, providing high-quality data and evidence-based support for clinical/translational research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2040
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2041
September 19, 2025
September 1, 2025
15.3 years
September 8, 2025
September 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival
OS: OS of subjects from recruiting to the time of death from any cause
12 month
Secondary Outcomes (1)
Disease free survival (DFS)
up to 10 years
Interventions
Enucleation, spleen-preserving distal pancreatectomy, or duodenum-preserving pancreatic head resection, etc
Eligibility Criteria
To establish and maintain a reliable multicenter real-world database for pancreatic SPN, providing high-quality data and evidence-based support for clinical/translational research.
You may qualify if:
- No restrictions on age, gender, or performance status;
- Pathologically/cytologically confirmed SPN;
- Compliance with follow-up requirements;
You may not qualify if:
- Non-neoplastic pancreatic lesions;
- Non-pancreatic primary tumors;
- Non-compliance with follow-up;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Shanghai Cancer Center
Shanghai, Special Administrative Region, 200032, China
Related Publications (1)
Hua Y, Hong X, Dai M, Li J, Yang S, Guo J, Wang W, Xu Q, Han X, Wang M, Huang N, Zheng H, Kleeff J, Liu Q, Wu W, Zhang T, Liao Q, Zhao Y. Local resection for solid pseudopapillary neoplasms of the pancreas shows improved postoperative gastrointestinal function and reduced mental stress: a multiquestionnaire survey from a large cohort. Int J Surg. 2023 Dec 1;109(12):3815-3826. doi: 10.1097/JS9.0000000000000702.
PMID: 37830944BACKGROUND
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Guopei Luo
Shanghai Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 19, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
December 30, 2040
Study Completion (Estimated)
December 30, 2041
Last Updated
September 19, 2025
Record last verified: 2025-09